Optometry

Sustained release fluocinolone acetonide has the potential to become an effective long-term treatment for DME.

Measure your inventory turns monthly.

The author discusses how MGD is a major source of morbidity and decreased quality of life for patients.

The pivotal study of a sustained-release dexamethasone intravitreal implant showed that it was a safe, effective option for the treatment of noninfectious intermediate and posterior uveitis.

In patients who have not undergone previous treatment, bevacizumab appears to be a safe and effective treatment for exudative age-related macular degeneration.

The key success factor for turning ideas into reality is planning.

Most aspects of ocular trauma are unique when practicing in a combat environment.

A single intravitreal injection of ocriplasmin is safe, effective, well-tolerated, and is the first pharmacologic treatment for symptomatic vitreomacular adhesion.

On March 16, LENSAR Inc. received 510 (k) clearance from the FDA to market its femtosecond laser system for lens fragmentation in addition to anterior capsulotomy during cataract surgery.

Given the unprecedented growth of interest in correction of monochromatic optical aberrations to improve the quality of pseudophakic vision, it is natural that the next step will be to investigate polychromatic light and its inherent aberrations.

What is in your lens toolbox?

A 3-D simultaneous stereoscopic retinal camera that allows stereo images to be taken in one shot, offers an automatic mosaic merge function, and provides a full 45-degree field angle in two-dimensional mode has been introduced by Kowa Optimed Inc.

The use of a trabecular microbypass stent in combination with cataract surgery in patients with mild-to-moderate open-angle glaucoma is safe and results in clinically safe and statistically significant reductions in IOP with fewer medications when compared with cataract surgery alone.

The debate over the need to remove the corneal epithelium when performing corneal collagen crosslinking will continue until long-term data from peer-reviewed studies become available to answer the question of whether a procedure done with the epithelium on results in sufficient crosslinking for long-term arrest of ectasia progression.

Potential treatments for the management of dry age-related macular degeneration are numerous, but so far, studies still are ongoing as to their therapeutic benefit.

A proprietary surgery system brings to laser vision correction surgeons the benefits of expertise in both femtosecond and excimer laser technology.

Oral fenretinide slowed the growth of geographic atrophy and reduced the incidence of choroidal neovascularization in patients who were treated over a 2-year period with a daily dose of the drug.

Use of a commercially available artificial tear product containing propylene glycol as a demulcent and phospholipids in a proprietary emulsion technology reduces tear evaporation for at least 60 minutes post-instillations in patients with aqueous deficient dry eye disease associated with a MGD.

A lubricating eye drop product seems to provide ocular relief for an extended period to patients with mild to moderate dry eye.

If we can help our patients understand the wisdom of leaving a written record of their desires should they suffer severe medical setbacks, they might avoid the problems that can occur from having their health care guided by presumably well-meaning family members who might be educationally or emotionally ill-equipped to make sound decisions.

Preoperative cone location appears to affect topographic and visual acuity outcomes of CXL, according to study results.

Pterygium recurrence rates may be significantly higher in Hispanic patients compared with Caucasian patients.

Patients with moderate to serve dry eye disease are dissatisfied with various dry eye therapies because they do not provide complete symptom relief.

A novel ocular surface interferometer may help physicians more accurately diagnose and monitor lipid-deficient evaporative dry eye.

Results of a study using optical coherence tomography to quantify the tear meniscus provide objective evidence that punctal plugs provide rapid and durable benefits when used from treatment of dry eye.

Findings from analyses of a dataset including more than 250,000 patients provide new information on refractive stability in unoperated eyes and are being applied to establish refractive targets after laser vision correction with the aim of achieving better long-term satisfaction.

Results of a randomized, clinical trial provide evidence to support use of a proprietary oral supplement containing omega-3 fatty acids as a mainstay in the management of dry eye disease.

Implantation of a synthetic intracorneal inlay has been associated with a history of failure when explored as a refractive surgical procedure.

State-of-the-art evaluation and emerging therapies for retinal degenerations are currently the focus of significant research.

Dry eye syndrome has been estimated to affect more than 5 million Americans, yet there is only one FDA-approved eye drop, cyclosporine ophthalmic emulsion 0.05%, for its treatment.